Why the study?
Does recent SARS-CoV-2 infection alter autonomic and haemodynamic function in young, otherwise healthy adults?
Does recent SARS-CoV-2 infection alter autonomic and haemodynamic function in young, otherwise healthy adults?
Answers are grounded in this paper and cite their sources.
Recent SARS-CoV-2 infection in young adults is associated with elevated resting muscle sympathetic nerve activity, highlighting potential post-viral autonomic dysfunction.
The coronavirus disease (COVID-19) is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its emergence in 2019 has elicited an ongoing pandemic, affecting millions of individuals worldwide. Internalization of SARS-CoV-2 by human cells occurs through the receptor angiotensin-converting enzyme type II (ACEII), a usually membrane-bound homologue of angiotensin-converting enzyme. ACEII is widely expressed on smooth muscle of the vasculature and organs such as lungs, heart, brain and intestine. Consequently, symptoms of SARS-CoV-2 infection include dyspnoea, chest pain and nausea/diarrhoea, amongst others. Another serious and persistent side effect of COVID-19 is autonomic dysfunction. With that, in a recent publication in The Journal of Physiology, Stute and colleagues sought to examine the impact of recent SARS-CoV-2 infection (COVID+) on autonomic and haemodynamic function in young, otherwise healthy adults (Stute et al. 2021). As the interplay between autonomic and vascular function is vital to cardiovascular homeostasis, the authors employed the gold standard of microneurography to measure muscle sympathetic nervous activity (MSNA) combined with continuous measures of blood pressure and heart rate. Data were collected at rest, during a sympathoexcitatory cold pressor test (CPT), and during an orthostatic challenge (the head-up tilt (HUT) test). The autonomic nervous system is an important regulator of beat-to-beat (acute) changes in blood pressure. Raw recordings of MSNA are typically rectified and integrated to provide multi-unit ‘bursts’ of sympathetic activity. The authors report, at rest, greater MSNA burst frequency (bursts per minute), incidence (bursts per 100 heart beats) and total activity (burst number and burst size) in recently infected young adults (3–8 weeks after symptom onset) compared to healthy controls. In response to a sympathoexcitatory manoeuvre, CPT, increases in MSNA burst frequency and burst incidence were not significantly different between groups. Notably, MSNA total activity during the CPT was also similar between groups; however, upon closer inspection the authors uncovered a greater peak response in control compared to COVID+ (Stute et al. 2021). The combination of findings is intriguing. Although not directly tested, it would be interesting to examine whether COVID+ individuals exhibit rapid (<15 s) increases in heart rate and/or cardiac output at the onset of CPT. This approach could subsequently load the arterial baroreceptors and limit the peak increase in MSNA. Greater vagal modulation of heart rate at baseline in the COVID+ individuals and group differences in burst incidence (bursts per 100 heart beats) support this possibility. However, without reported measures of cardiac output, stroke volume and total peripheral resistance in addition to early time course data (first 30 s of CPT), interpretation of the haemodynamic factors underlying an attenuated MSNA peak response to CPT is limited. Alternatively, it could be that the COVID+ group is in such a sympathetically dominant state at rest that a further increase in sympathetic activity, even to a sympathoexcitatory manoeuvre such as CPT (i.e. a ‘ceiling’ effect), is not possible. The authors allude to this possibility and liken it to what has been observed in patients suffering severe cerebrovascular events. During a HUT test, blood pools in the legs due to the absence of muscle contraction, thereby unloading the baroreceptors and causing a baroreflex-mediated increase in sympathetic activity. In response to HUT, both groups increased MSNA burst frequency and total activity and these increases did not differ between groups (no position × group interaction). These results suggest arterial baroreflex-mediated increases in MSNA to prevent syncope are unaffected by recent SARS-CoV-2 infection. Interestingly, the rise in MSNA burst incidence was attenuated in COVID+ individuals. The COVID+ group also had a greater heart rate response to the 60° HUT, suggesting greater reliance on heart rate and/or cardiac output to prevent syncope. This is interesting to consider, as one of the autonomic manifestations associated with ‘long COVID’ is postural orthostatic tachycardia syndrome (POTS). Thus, it may be that the heart rate observed during 60° HUT in the COVID+ group is the preclinical manifestation of autonomic dysfunction. Notably, POTS is observed more often in female patients, whereas there is greater mortality and morbidity in men with SARS-CoV-2. Because of these observed sex differences, future research is warranted to directly examine the sex-specific impacts of the SARS-CoV-2 virus on sympathetic regulation of blood pressure. As mentioned, SARS-CoV-2 is internalized by the cell through the ACEII receptor. Molecularly, internalization of SARS-CoV-2 causes a reduction in ACEII activity by depletion of membrane-bound ACEII, thereby increasing the levels of free circulating angiotensin II (ANGII). Interestingly, ANGII works both centrally (within the brain) to increase sympathetic outflow and in the peripheral sympathetic nerve terminals to elicit sympathetic neurotransmission (Reid, 1992). Moreover, ANGII has been shown to alter baroreflex control of heart rate, such that an increase in blood pressure is not met with bradycardia. Interestingly, at rest the COVID+ group had a lesser fall in blood pressure after a MSNA burst compared to controls. These data suggest blood pressure in COVID+ patients is maintained, at least in part, by other vascular control mechanisms. As a potent vasoconstrictor, ANGII in excess may thus contribute to higher baseline blood pressures reported by Stute and colleagues in the COVID+ group (average systolic blood pressure: 135 ± 11 mmHg) (Stute et al. 2021). However, the healthy control group also exhibited stage I hypertension as defined by the American Heart Association (average systolic blood pressure 134 ± 11 mmHg), which limits subsequent interpretation of findings. ANGII may also activate macrophages and other immune cells to produce inflammatory cytokines. Interestingly, a hallmark of SARS-CoV-2 is severe hyperactivity of the immune system, termed ‘cytokine storms’. Whether these cytokine storms are mediated by ANGII is unclear, but proinflammatory mediators appear to relay to the brain and may elicit an increase in sympathetic outflow through the hypothalamic–pituitary–adrenalaxis (Yang et al. 2021). Robust inflammatory responses induced by hyperactivity of the immune system also elicit persistent elevations in MSNA, such as those documented in disorders like rheumatoid arthritis (Adlan et al. 2017). As mRNA from SARS-CoV-2 has been detected from individuals up to 40 days after symptom onset (Yang et al. 2020), it is reasonable to propose the virus is still present within the body increasing ANGII and inflammation, but the viral load is not great enough to elicit visible or physiological symptoms – that is, until the system is tested, such as with HUT or CPT. It would be interesting to include measures of inflammation and/or a longitudinal study design to determine the time course of the persistent elevations in MSNA and/or inflammation. Results may also shed some light on the aetiology and/or pathogenesis of the increasingly common ‘long hauler’ or ‘long COVID’ syndrome. Stute and colleagues report their participants being either sedentary or recreationally physically active. Exercise itself is associated with decreased levels of inflammation. Regular exercise can also reduce the risk of both all-cause and disease-specific mortality. Therefore, it would be interesting to explore further the ability of regular exercise to prevent autonomic dysfunction associated with COVID-19. Epidemiological studies consistently show an association between higher levels of physical activity and reduced white blood cell count, C-reactive protein, interleukin (IL)-6, IL-18 and tumour necrosis factor α, which influence prevailing levels of sympathetic activity. Moreover, regular physical activity also induces a shift in the renin–angiotensin system towards angiotensin 1-7, which evokes sympathoinhibition as well as vasodilatation and anti-inflammation. Therefore, it is reasonable to speculate that regular physical activity or the acute lack thereof may influence the evolution and post-infection symptoms of COVID-19. Cardiovascular and autonomic adaptations to exercise are reversed following 2–4 weeks of decreased physical activity (i.e. detraining or acute illness causing an inability to exercise). This notion of sedentary behaviour coupled with increases in resting MSNA could contribute to the impaired endothelium-dependent dilatation the authors published in a previous study following COVID-19 infection. Indeed, increases in MSNA are associated with endothelial dysfunction. Conversely, because physical activity elicits a reduction in sympathetic activity and improvements in endothelial function, it would be interesting and of importance to know if MSNA and endothelium-dependent dilatation returned to pre-infection levels after resuming or beginning a regular exercise routine in the COVID+ patients studied. In conclusion, Stute and colleagues laid the cornerstone for better understanding of the autonomic and cardiovascular effects following infection via SARS-CoV-2. Further research is required to understand both the aetiology and the clinical implications of elevated MSNA following SARS-CoV-2 infection in adults and how this may translate to at-risk individuals (e.g. obesity, hypertension, diabetes). The authors should be commended for the first of its kind study with direct clinical translation to our ongoing global pandemic. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. None declared. All authors have read and approved the final version of this manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed. None.
No takes yet. Share an insight, caveat, or question.
Moreno‐Cabañas et al. (2021) conducted an editorial in COVID-19. Recent SARS-CoV-2 infection vs. Healthy controls was evaluated on Muscle sympathetic nervous activity (MSNA) at rest.
Synapse has enriched 10 related papers. Consider them for comparative context: